UM completes 1st stage of stem-cell therapy for ALS

With an operation to inject stem cells into the spinal cord of an ALS patient on Oct. 2, a team at the University of Michigan completed the first stage of its U.S. Food and Drug Administration trials to test a new therapy for the deadly neurological disease.

http://www.crainsdetroit.com/article/20131020/NEWS/310209990/um-completes-1st-stage-of-stem-cell-therapy-for-als?CSAuthResp=1%3A573517357310515%3A246601%3A512%3A24%3Aapproved%3AD8AB9226D1D0723D2605C45E7E01C0FA